You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TMC-207

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leprosy, Multibacillary Trial in Bauru, Manaus (Bedaquiline 200 mg)

Active, not recruiting
  • Leprosy, Multibacillary
  • Bedaquiline 200 mg
  • Bauru, Brazil
  • +1 more
Aug 2, 2022

Tuberculosis, HIV Trial in United States (Efavirenz (EFV), TMC207)

Completed
  • Tuberculosis
  • HIV
  • San Francisco, California
  • +4 more
Oct 28, 2021

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +5 more
  • Bedaquiline 100 MG
  • +4 more
  • Pune, India
  • +9 more
Mar 2, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Multidrug Resistant Tuberculosis Trial in Belarus, South Africa, Uzbekistan (Bedaquiline, Pretomanid, Moxifloxacin)

Recruiting
  • Multidrug Resistant Tuberculosis
  • Minsk, Belarus
  • +5 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

Recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

Completed
  • Pulmonary Tuberculosis
  • Ysterplaat, Cape Town, South Africa
  • +2 more
Nov 19, 2020

Tuberculosis, Multidrug-Resistant Trial in Kiyose, Sakai (TMC207 (bedaquiline), Background Regimen (BR))

Completed
  • Tuberculosis, Multidrug-Resistant
  • TMC207 (bedaquiline)
  • Background Regimen (BR)
  • Kiyose, Japan
  • +1 more
Oct 30, 2019

Tuberculosis Trial in Lincoln (TMC207, rifapentine, rifampicin)

Completed
  • Tuberculosis
  • Lincoln, Nebraska
    Celerion (MDS Pharma Services)
Sep 4, 2019

Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Healthy Trial in Antwerpen (Bedaquiline (Test formulation), Bedaquiline (Reference formulation))

Completed
  • Healthy
  • Bedaquiline (Test formulation)
  • Bedaquiline (Reference formulation)
  • Antwerpen, Belgium
    SGS Life Science Services
Jan 21, 2020

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
Has Results
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Osteoarthritis of Trapeziometacarpal Joint Trial in Sao Paulo (Day Splint, Night Splint)

Completed
  • Osteoarthritis of Trapeziometacarpal Joint
  • Day Splint
  • Night Splint
  • Sao Paulo, SP, Brazil
    Federal University of Sao Paulo - Rheumatology Division
Dec 13, 2022

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Trauma-Sensitive Mindfulness and Compassion Intervention

Completed
  • Complex Post-Traumatic Stress Disorder
  • TMC Treatment Approach
  • Vikersund, Norway
    Modum Bad
Aug 16, 2023

EGFR Mutant Advanced NSCLC Trial (BBT-207)

Not yet recruiting
  • EGFR Mutant Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jun 16, 2023

Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Jan 23, 2023

Elder Abuse, Surveys and Questionnaires, Self Neglect Trial in Houston (NCAEM EM-SART Pre-Screen)

Not yet recruiting
  • Elder Abuse
  • +6 more
  • NCAEM EM-SART Pre-Screen
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Apr 8, 2023

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Postoperative Pain Trial in Basel (Lidocaine, NaCl 0,9%)

Active, not recruiting
  • Postoperative Pain
  • Basel, Switzerland
    Division of Thoracic Surgery,University Hospital of Basel
Mar 21, 2022